MATRIX PHARMACEUTICALS ApS
CVR 29625867 · Private limited company (ApS) · Active · Low risk
MATRIX PHARMACEUTICALS ApS is a Private limited company (ApS), founded on , based in København Ø. The company is registered in the industry engroshandel med medicinalvarer og sygeplejeartikler. Our model estimates a bankruptcy risk of 0.5% over the next 12 months, which is 0.4 times the average for Danish companies. 20 annual reports have been published, of which 1 more than six months after the end of the financial year. The latest annual report (31 Dec 2025) shows equity of DKK 589k and a net result of DKK 589k. CEO: Karsten Høilund Skafte.
Bankruptcy risk for MATRIX PHARMACEUTICALS ApS
0.4 × the average (1.41%) · higher risk than 60% of active Danish companies
Increases the risk
Reduces the risk
The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.
Company details
- CVR number
- 29625867
- Status
- Active
- Company type
- Private limited company (ApS)
- Founded
- (20 years)
- Address
- c/o Karsten Skafte, Amerika Plads 32B, 5. 2
2100 København Ø - Municipality
- København
- Industry
- Engroshandel med medicinalvarer og sygeplejeartikler (464610)
Bankruptcies in the industry: Engroshandel med andre maskiner og andet udstyr - Share capital
- DKK 500k
- Employees
- 1 (2018)
- Auditor
- BHA STATSAUTORISERET REVISION APS
- Audit opted out
- No
Warning signs
| Annual reports filed late | 1 of 20 |
| Missing annual report | No |
| Negative equity | No |
| Equity ratio | 100.0% |
| Current ratio | – |
| Moves (last 2 years) | 0 |
| CEO changes in total | 0 |
| CEO's previous bankruptcies | 0 |
| Other companies at the address | 6 |
| Going-concern uncertainty | No |
Financials and key figures
| Financial year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Revenue | DKK 1.1m | DKK 981k | DKK 1.2m |
| Gross profit | DKK 818k | DKK 509k | DKK 1.2m |
| Net profit | DKK 589k | DKK 440k | DKK 544k |
| Equity | DKK 589k | DKK 60k | DKK -44k |
| Total assets | DKK 589k | DKK 269k | DKK 91k |
| Cash | DKK 491k | DKK 201k | – |
| Short-term debt | – | DKK 209k | – |
| Avg. employees | 1 | 1 | – |
Latest annual report: Reporting class B · auditor's statement: No assurance.
Filed annual reports
| Reporting period | Published | Days after period end | |
|---|---|---|---|
| 1 Jan 2025 – 31 Dec 2025 | 166 | ||
| 1 Jan 2024 – 31 Dec 2024 | 178 | ||
| 1 Jan 2023 – 31 Dec 2023 | 176 | ||
| 1 Jan 2022 – 31 Dec 2022 | 171 | ||
| 1 Jan 2021 – 31 Dec 2021 | 154 | ||
| 1 Jan 2020 – 31 Dec 2020 | 97 | ||
| 1 Jan 2019 – 31 Dec 2019 | 244 | Late | |
| 1 Jan 2018 – 31 Dec 2018 | 157 | ||
| 1 Jan 2017 – 31 Dec 2017 | 157 | ||
| 1 Jan 2016 – 31 Dec 2016 | 151 | ||
| 1 Jan 2015 – 31 Dec 2015 | 161 | ||
| 1 Jan 2014 – 31 Dec 2014 | 167 | ||
| 1 Jan 2013 – 31 Dec 2013 | 157 | ||
| 1 Jan 2012 – 31 Dec 2012 | 163 | ||
| 1 Jan 2011 – 31 Dec 2011 | 158 | ||
| 1 Jan 2010 – 31 Dec 2010 | 173 | ||
| 1 Jan 2009 – 31 Dec 2009 | 152 | ||
| 1 Jan 2008 – 31 Dec 2008 | 161 | ||
| 1 Jan 2007 – 31 Dec 2007 | 149 | ||
| 26 Jun 2006 – 31 Dec 2006 | 161 |
The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| CEO | Karsten Høilund Skafte | Current | |
| Board | Karsten Høilund Skafte | Current | |
| Board | Mariann Florin Skafte | ||
| Board | Stefan Gliwitzki-Grabner | ||
| Board | Christoph Kerstein | ||
| Board | Peter Lassen | ||
| Board | Anders Leif Håkansson | ||
| Board | Steen Larsen | ||
| Owner (100%) | Karsten Høilund Skafte | Current | |
| Owner (100%) | KHS HOLDING ApS | Current | |
| Owner (50%) | Karsten Høilund Skafte | ||
| Owner (50%) | KHS HOLDING ApS | ||
| Owner (50%) | Evolan Pharma AB | ||
| Auditor | BHA STATSAUTORISERET REVISION APS | Current | |
| Auditor | GRANT THORNTON, STATSAUTORISERET REVISIONSAKTIESELSKAB | ||
| Auditor | PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB | ||
| Founder | KHS HOLDING ApS | Current |
The CEOs' other companies
Karsten Høilund Skafte – 7 other companies
- 1A FARMA A/S Fusioneret
- BIOCUR A/S Fusioneret
- FLORIN HEALTHCARE ApS Opløst
- HEXAL A/S Fusioneret
- HEXAL SCANDINAVIA A/S Fusioneret
- HEXASCAN MEDICAL PRODUCTS ApS Opløst
- KHS HOLDING ApS Active
Address history (4 moves)
| c/o Karsten Skafte, Amerika Plads 32B, 5. 2, 2100 København Ø | |
| Tuborg Boulevard 12, 3., 2900 Hellerup | |
| Kongevejen 100, 3480 Fredensborg | |
| Marielundvej 48, 3., 2730 Herlev | |
| c/o KHS Holding ApS, Kongevejen 100, 3480 Fredensborg |
Former names
| MATRIX PHARMACEUTICALS ApS | – now |
| MATRIX PHARMACEUTICALS A/S | – |
Employees per year
Other companies at the same address
- Alan Jordan Consulting ApS Opløst
- Amatech Holding ApS Active
- Caspercho Holding ApS Active
- KHS HOLDING ApS Active
- PIF Invest Holding ApS Active
- Play It Forward ApS Active
Similar companies in København
- ALFASCAN ApS København K
- LUNDBECK PHARMA A/S Valby
- ASTRAZENECA A/S København V
- Sundvik ApS Vanløse
- DEXCOM DENMARK, ApS København Ø
- Nitrilehandsker.dk ApS Valby
- DePuy Synthes (Denmark) ApS København K
- ELSE NORDICS APS København S
- MSD Animal Health A/S København V
- DentFriends ApS København S
- Sanad Health ApS København N
- Venteus Medical Devices (ROW) ApS København Ø
Questions and answers about MATRIX PHARMACEUTICALS ApS
Has MATRIX PHARMACEUTICALS ApS gone bankrupt?
No, MATRIX PHARMACEUTICALS ApS is not registered as bankrupt in the CVR register. Its status is: active.
What is the bankruptcy risk of MATRIX PHARMACEUTICALS ApS?
Our model estimates a bankruptcy risk of 0.5% over the next 12 months (low risk), which is 0.4 times the average for Danish companies.
Who is the CEO of MATRIX PHARMACEUTICALS ApS?
Karsten Høilund Skafte is the CEO of MATRIX PHARMACEUTICALS ApS.
Who is the auditor of MATRIX PHARMACEUTICALS ApS?
MATRIX PHARMACEUTICALS ApS most recently used BHA STATSAUTORISERET REVISION APS.
When was MATRIX PHARMACEUTICALS ApS founded?
MATRIX PHARMACEUTICALS ApS was founded on 26 June 2006.
What is the equity of MATRIX PHARMACEUTICALS ApS?
Equity was DKK 589k according to the annual report for the period ending 31 December 2025.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.